Verastem Oncology
VSTM
#8393
Rank
ยฃ86.77 M
Marketcap
ยฃ2.16
Share price
4.43%
Change (1 day)
-71.81%
Change (1 year)

Revenue for Verastem Oncology (VSTM)

Revenue in 2024 (TTM): ยฃ7.9 M

According to Verastem Oncology 's latest financial reports the company's current revenue (TTM) is ยฃ7.61 M. In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of ยฃ2.14 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verastem Oncology from 2011 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ7.9 M
2023 N/A-100%
2022 ยฃ2.14 M41.46%
2021 ยฃ1.51 M-97.66%
2020 ยฃ64.83 M392.95%
2019 ยฃ13.15 M-37.19%
2018 ยฃ20.93 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ7.74 M 1.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ42.39 B 556,320.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ9.51 B 124,776.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ30.07 B 394,569.01%๐Ÿ‡ฌ๐Ÿ‡ง UK